Bone Marrow Aspirate Concentrate (BMAC) Treatment for Knee Osteoarthritis

Summary

The purpose of the ACCELERATE3 trial is to assess the efficacy of a single intra-articular (IA) injection of autologous BMAC, in one or both knees, compared to a single IA injection of Standard of Care (SOC) in patients with mild to severe knee OA.

Timeline

Start

2024-09

Primary completion

2026-08

Completion

2026-12

Drugs

Indications